Gut microbiota-involved mechanisms in enhancing systemic exposure of ginsenosides by coexisting polysaccharides in ginseng decoction

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Zhou, Shan Shan ^a,b   Xu, Jun ^c   Zhu, He ^a   Wu, Jie ^b   Xu, Jin Di ^a   Yan, Ru ^d   Li, Xiu Yang ^a,b   Liu, Huan Huan ^a,b   Duan, Su Min ^b   Wang, Zhuo ^b   Chen, Hu Biao ^c   Shen, Hong ^b   Li, Song Lin ^a,b  

^a NANJING UNIVERSITY OF CHINESE MEDICINE   (China)

^b INSTITUTE OF CHINESE MATERIA MEDICA   (China)

^c HONG KONG BAPTIST UNIVERSITY   (Hong Kong)

^d University of Macau   (Macao)

Author keywords

[No Author keywords available]

Indexed keywords

GINSENOSIDE; POLYSACCHARIDE;

ANIMAL; BLOOD; CHEMISTRY; HUMAN; INTESTINE; MICROBIOLOGY; MICROFLORA; PANAX; RAT;

ANIMALS; GINSENOSIDES; HUMANS; INTESTINES; MICROBIOTA; PANAX; POLYSACCHARIDES; RATS;

EID: 84960173068     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep22474     Document Type: Article

References (60)

1. Tu, Y. Y. The discovery of artemisinin (qinghaosu) and gifts from Chinese medicine. Nat Med 17, 1217-1220 (2011).
2. Cheung, F. TCM made in China. Nature 480, S82-S83 (2011).
3. Liu, X., Wu, W. Y., Jiang, B. H., Yang, M. & Guo, D. A. Pharmacological tools for the development of traditional Chinese medicine. Trends Pharmacol Sci 34, 620-628 (2013).
4. Yang, M. et al. Phytochemical analysis of traditional Chinese medicine using liquid chromatography coupled with mass spectrometry. J Chromatogr A 1216, 2045-2062 (2009).
5. Li, S. P., Wu, D. T., Lv, G. P. & Zhao, J. Carbohydrates analysis in herbal glycomics. Trac-Trend Anal Chem 52, 155-169 (2013).
6. Jia, W., Li, H. K., Zhao, L. P. & Nicholson, J. K. Gut microbiota: a potential new territory for drug targeting. Nat Rev Drug Discov 7, 123-129 (2008).
7. Newman, D. J. & Cragg, G. M. Natural products as sources of new drugs over the 30 years from 1981 to 2010. J Nat Prod 75, 311-335 (2012).
8. Luo, G., Wang, Y., Liang, Q. & Liu, Q. in Systems biology for traditional Chinese medicine (John Wiley & Sons, Hoboken; 2012).
9. Li, P., Qi, L. W., Liu, E. H., Zhou, J. L. & Wen, X. D. Analysis of Chinese herbal medicines with holistic approaches and integrated evaluation models. Trac-Trend Anal Chem 27, 66-77 (2008).
10. Chen, Q., Xiao, S., Li, Z. H., Ai, N. & Fan, X. H. Chemical and metabolic profiling of Si-Ni decoction analogous formulae by high performance liquid chromatography-mass spectrometry. Sci Rep-Uk 5, doi: 10.1038/Srep11638 (2015).
11. Xu, J. D. et al. Ultra-high performance liquid chromatography coupled with photo-diode array and quadrupole/time-of-flight mass spectrometry based chemical profiling approach to evaluate the influence of preparation methods on the holistic quality of Qiong-Yu-Gao, a traditional complex herbal medicine. J Chromatogr A 1304, 154-168 (2013).
12. Yan, Y. et al. HPLC-DAD-Q-TOF-MS/MS analysis and HPLC quantitation of chemical constituents in traditional Chinese medicinal formula Ge-Gen decoction. J Pharm Biomed Anal 80, 192-202 (2013).
13. Lee, J. W. et al. Systems metabolic engineering of microorganisms for natural and non-natural chemicals. Nat Chem Biol 8, 536-546 (2012).
14. van Duynhoven, J. et al. Metabolic fate of polyphenols in the human superorganism. P Natl Acad Sci USA 108, 4531-4538 (2011).
15. Selma, M. V., Espin, J. C. & Tomas-Barberan, F. A. Interaction between phenolics and gut microbiota: role in human health. J Agr Food Chem 57, 6485-6501 (2009).
16. Hostetler, G. et al. Flavone deglycosylation increases their anti-inflammatory activity and absorption. Mol Nutr Food Res 56, 558-569 (2012).
17. Koropatkin, N. M., Cameron, E. A. & Martens, E. C. How glycan metabolism shapes the human gut microbiota. Nat Rev Microbiol 10, 323-335 (2012).
18. Hou, S. X. Theory and practice for design of modern Chinese medicine preparation. (People's Medical Publishing House, Beijing; 2010).
19. Lam, W. et al. The four-herb Chinese medicine PHY906 reduces chemotherapy-induced gastrointestinal toxicity. Sci Transl Med 2 (2010), doi: 10.1126/scitranslmed.3001270.
20. Wang, L. et al. Dissection of mechanisms of Chinese medicinal formula Realgar-Indigo naturalis as an effective treatment for promyelocytic leukemia. P Natl Acad Sci USA 105, 4826-4831 (2008).
21. Xu, J. et al. Structural modulation of gut microbiota during alleviation of type 2 diabetes with a Chinese herbal formula. Isme J 9, 552-562 (2015).
22. Tremaroli, V. & Backhed, F. Functional interactions between the gut microbiota and host metabolism. Nature 489, 242-249 (2012).
23. Clemente, J. C., Ursell, L. K., Parfrey, L. W. & Knight, R. The Impact of the Gut Microbiota on Human Health: An Integrative View. Cell 148, 1258-1270 (2012).
24. Chang, C. J. et al. Ganoderma lucidum reduces obesity in mice by modulating the composition of the gut microbiota. Nat Commun 6, doi: ARTN 7489 (2015).
25. Ge, K. J. Books on ten magic herbs. (People's Medical Publishing House, Beijing; 1956).
26. Li, S. L. et al. Decocting-induced chemical transformations and global quality of Du-Shen-Tang, the decoction of ginseng evaluated by UPLC-Q-TOF-MS/MS based chemical profiling approach. J Pharm Biomed Anal 53, 946-957 (2010).
27. Lee, C. H. & Kim, J. H. A review on the medicinal potentials of ginseng and ginsenosides on cardiovascular diseases. J Ginseng Res 38, 161-166 (2014).
28. Niu, T. et al. Bioactivity and bioavailability of ginsenosides are dependent on the glycosidase activities of the A/J mouse intestinal microbiome defined by pyrosequencing. Pharm Res-Dordr 30, 836-846 (2013).
29. Qi, L. W., Wang, C. Z. & Yuan, C. S. Ginsenosides from American ginseng: chemical and pharmacological diversity. Phytochemistry 72, 689-699 (2011).
30. Qi, L. W., Wang, C. Z. & Yuan, C. S. Isolation and analysis of ginseng: advances and challenges. Nat Prod Rep 28, 467-495 (2011).
31. Xu, J. et al. A novel and rapid HPGPC-based strategy for quality control of saccharide-dominant herbal materials: Dendrobium officinale, a case study. Anal Bioanal Chem 406, 6409-6417 (2014).
32. Sun, Y. X. Structure and biological activities of the polysaccharides from the leaves, roots and fruits of Panax ginseng CA Meyer: An overview. Carbohyd Polym 85, 490-499 (2011).
33. Lemmon, H. R., Sham, J., Chau, L. A. & Madrenas, J. High molecular weight polysaccharides are key immunomodulators in North American ginseng extracts: characterization of the ginseng genetic signature in primary human immune cells. J Ethnopharmacol 142, 1-13 (2012).
34. Li, S. L. et al. Ultra-high-performance liquid chromatography-quadrupole/time of flight mass spectrometry based chemical profiling approach to rapidly reveal chemical transformation of sulfur-fumigated medicinal herbs, a case study on white ginseng. J Chromatogr A 1231, 31-45 (2012).
35. Kuo, Y. H., Tsai, W. J., Loke, S. H., Wu, T. S. & Chiou, W. F. Astragalus membranaceus flavonoids (AMF) ameliorate chronic fatigue syndrome induced by food intake restriction plus forced swimming. J Ethnopharmacol 122, 28-34 (2009).
36. Wang, X. Y. et al. Metabolic regulatory network alterations in response to acute cold stress and ginsenoside intervention. J Proteome Res 6, 3449-3455 (2007).
37. Prentiss, P. G. et al. The metabolism of choline by the germfree rat. Arch Biochem Biophys 94, 424-429 (1961).
38. Alwaiz, M., Mikov, M., Mitchell, S. C. & Smith, R. L. The exogenous origin of trimethylamine in the mouse. Metabolism 41, 135-136 (1992).
39. Swann, J. R. et al. Systemic gut microbial modulation of bile acid metabolism in host tissue compartments. P Natl Acad Sci USA 108, 4523-4530 (2011).
40. Dumas, M. E. et al. Metabolic profiling reveals a contribution of gut microbiota to fatty liver phenotype in insulin-resistant mice. P Natl Acad Sci USA 103, 12511-12516 (2006).
41. Thomas, C. et al. TGR5-mediated bile acid sensing controls glucose homeostasis. Cell Metab 10, 167-177 (2009).
42. Henao-Mejia, J. et al. Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity. Nature 482, 179-185 (2012).
43. Ley, R. E., Turnbaugh, P. J., Klein, S. & Gordon, J. I. Microbial ecology - human gut microbes associated with obesity. Nature 444, 1022-1023 (2006).
44. Schwiertz, A. et al. Microbiota and SCFA in lean and overweight healthy subjects. Obesity 18, 190-195 (2010).
45. Bouhnik, Y. et al. The capacity of nondigestible carbohydrates to stimulate fecal bifidobacteria in healthy humans: a double-blind, randomized, placebo-controlled, parallel-group, dose-response relation study. Am J Clin Nutr 80, 1658-1664 (2004).
46. Martens, E. C. et al. Recognition and degradation of plant cell wall polysaccharides by two human gut symbionts. Plos Biol 9 (2011).
47. Mohnen, D. Pectin structure and biosynthesis. Curr Opin Plant Biol 11, 266-277 (2008).
48. Zhang, X. et al. Total fractionation and characterization of the water-soluble polysaccharides isolated from Panax ginseng C. A. Meyer. Carbohyd Polym 77, 544-552 (2009).
49. Gao, Q. P., Kiyohara, H., Cyong, J. C. & Yamada, H. Chemical-properties and anti-complementary activities of polysaccharide fractions from roots and leaves of Panax Ginseng. Planta Med, 9-12 (1989).
50. Tomoda, M. et al. Characterization of 2 novel polysaccharides having immunological activities from the root of Panax Ginseng. Biol Pharm Bull 16, 1087-1090 (1993).
51. Mahowald, M. A. et al. Characterizing a model human gut microbiota composed of members of its two dominant bacterial phyla. P Natl Acad Sci USA 106, 5859-5864 (2009).
52. Kaneko, H. & Nakanishi, K. Proof of the mysterious efficacy of ginseng: Basic and clinical trials: Clinical effects of medical ginseng, Korean red ginseng: Specifically, its anti-stress action for prevention of disease. J Pharmacol Sci 95, 158-162 (2004).
53. Wang, J. et al. Anti-fatigue activity of the water-soluble polysaccharides isolated from Panax ginseng C. A. Meyer. J Ethnopharmacol 130, 421-423 (2010).
54. Bae, E. A., Shin, J. E. & Kim, D. H. Metabolism of ginsenoside Re by human intestinal microflora and its estrogenic effect. Biol Pharm Bull 28, 1903-1908 (2005).
55. Bae, E. A. et al. Metabolism of ginsenoside Rc by human intestinal bacteria and its related antiallergic activity. Biol Pharm Bull 25, 743-747 (2002).
56. Chi, H., Kim, D. H. & Ji, G. E. Transformation of ginsenosides Rb2 and Rc from Panax ginseng by food microorganisms. Biol Pharm Bull 28, 2102-2105 (2005).
57. Gummesson, A. et al. Intestinal permeability is associated with visceral adiposity in healthy women. Obesity 19, 2280-2282 (2011).
58. Shin, H. Y. et al. Purification and characterization of ginsenoside Ra-hydrolyzing beta-D-Xylosidase from Bifidobacterium breve K-110, a human intestinal anaerobic bacterium. Biol Pharm Bull 26, 1170-1173 (2003).
59. Wan, J. Y. et al. Biotransformation and metabolic profile of American ginseng saponins with human intestinal microflora by liquid chromatography quadrupole time-of-flight mass spectrometry. J Chromatogr A 1286, 83-92 (2013).
60. Bae, E. A., Park, S. Y. & Kim, D. H. Constitutive beta-glucosidases hydrolyzing ginsenoside Rb1 and Rb2 from human intestinal bacteria. Biol Pharm Bull 23, 1481-1485 (2000).